Sheng Kuo is a Nephrology physician affiliated with New York Hospital Queens. OpenAlex indexes 15 publications with 618 citations (h-index 5); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Cerebellar DBS in SCA1 and SCA3 Study
Sponsor: Gordon H. Baltuch
- Clinical Trial Readiness for SCA1 and SCA3
Sponsor: The Methodist Hospital Research Institute
- Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias
Sponsor: Lauren Moore
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Travere Therapeutics, Inc.Program year20241 payment
- Lilly USA, LLCProgram year20241 payment
- AstraZeneca Pharmaceuticals LPProgram year202310 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
11 NIH research awards on record, funded 2013–2026 per NIH RePORTER. The latest:
- Human Cerebellar Deep Brain Stimulation and Recordings in Spinocerebellar Ataxias
Columbia University Health Sciences
FY2026$1,900,375UH3NS140720 - Developing Purkinje Cell Synaptic Therapies to Restore Circuit Function in Cerebellar Degeneration
Columbia University Health Sciences
FY2026$600,292R01NS136686 - Targeting Cerebellar Endoplasmic Reticulum Calcium Handling in Essential Tremor
Columbia University Health Sciences
FY2026$585,748R01NS124854
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Coexistence of Minimal Change Disease and Acquired Thrombotic Thrombocytopenic Purpura: A Case Report
Journal of the American Society of Nephrology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
David Slotwiner, MD
New York Hospital Queens
Daniel Skupski, MD
New York Hospital Queens
Bruce Spinowitz, MD
New York Hospital Queens
Joseph Tibaldi, MD, FACP
New York Hospital Queens
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”